Status:
COMPLETED
Unifying Advanced Treatment With Advanced Imaging
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Institute of Clinical Radiology and Nuclear Medicine Mannheim
Siemens Healthcare Diagnostics Inc
Conditions:
Gastrointestinal Stromal Tumor (GIST)
Eligibility:
All Genders
18+ years
Brief Summary
The study investigates response assessment of gastrointestinal stromal tumors using Dual Energy CT (DECT) in patients undergoing targeted therapy with a TKI Inhibitor.
Detailed Description
Patients treated with targeted therapies by tyrosine kinase inhibition (TKI) almost always show different response patterns than tumors treated with cytotoxic chemotherapy. Tumor manifestations treate...
Eligibility Criteria
Inclusion
- General inclusion criteria for TKI treatment according to general medical standard procedures
Exclusion
- General inclusion criteria for TKI treatment according to general medical standard procedures
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT03404076
Start Date
December 1 2014
End Date
December 1 2020
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Center Mannheim
Mannheim, Germany